Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-27 Ross Leonard S Exercise or conversion · Restricted Stock Units −6,667 6,667
2019-06-27 Paggiarino Dario A. Chief Medical Officer Exercise or conversion +10,000 48,437
2019-06-27 Paggiarino Dario A. Chief Medical Officer Shares withheld for taxes −2,940 $1.65 $5K 45,497
2019-06-27 Paggiarino Dario A. Chief Medical Officer Exercise or conversion · Restricted Stock Units −10,000 10,000
2019-06-27 Lurker Nancy President & CEO Exercise or conversion +40,000 325,200
2019-06-27 Lurker Nancy President & CEO Exercise or conversion · Restricted Stock Units −40,000 40,000
2019-06-25 ROGERS MICHAEL W Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2019-06-25 Mazzo David J Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2019-06-25 Duker Jay S. Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2019-06-25 Landis John B. Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2019-06-25 Godshall Douglas Evan Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2019-06-25 Peterson Kristine Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2019-06-25 ANDO GORAN Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2019-06-25 Lurker Nancy President & CEO Grant or award · Restricted Stock Units +411,523 411,523
2019-06-25 Lurker Nancy President & CEO Grant or award · Stock Option (Right to Buy) +930,000 930,000
2019-06-25 Price David CFO Grant or award · Stock Option (Right to Buy) +300,000 300,000
2019-06-25 Paggiarino Dario A. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +370,000 370,000
2019-06-21 ROGERS MICHAEL W Director Exercise or conversion +6,667 119,167
2019-06-21 ROGERS MICHAEL W Director Exercise or conversion · Deferred Stock Units −6,667 0
2019-06-21 Mazzo David J Director Exercise or conversion +8,333 166,333

Page 35 of 40 · 795 trades